IGC Pharma, Inc.IGCNYSE
Loading
Cash Flow Under PressureContracting
Percentile Rank43
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-4.79M
Near historical average
Percentile
P43
Within normal range
Streak
4 yr
Consecutive growthContracting
Average
$-5.08M
Historical baseline
PeriodValueYoY Change
2025$-4.79M+7.8%
2024$-5.20M+26.2%
2023$-7.05M+5.6%
2022$-7.46M+30.9%
2021$-10.80M-24.5%
2020$-8.68M-160.6%
2019$-3.33M-72.4%
2018$-1.93M-38.8%
2017$-1.39M-782.1%
2016$-157702.00-